Promising Lupus Research Leading to Better Treatment

• Lupus Research

  Scientific and Technology Breakthroughs Show Promise for Lupus and Other Immunologic Diseases The Lupus Research Alliance is pleased to share a promising scientific breakthrough reported in the New York Times with real potential to revolutionize lupus treatment. Scientists at the University of California, San Francisco developed an innovative way to engineer genes of the body’s immune system to treat immunologic diseases like lupus, rheumatoid arthritis, cancer and HIV. Read More   ► Get Inspired! The Lupus Research Alliance New York City Lupus Research Reception featured incredible speakers whose remarks are well worth sharing: Larry Schreiber, President & CEO of Empire Blue Cross/Blue Shield; Dr. Meggan Mackay, The Feinstein Institute; and Kenneth Farber, President & CEO, Lupus Research Alliance. Learn More   ► Introducing This Month's Featured Blogger Our own staffer, Al Roy, describes clinical trials and why participation by people with lupus is so important. Read Now   ►

  FORWARD TO A FRIEND | PRIVACY POLICY | UNSUBSCRIBE Lupus Research Alliance is a 501(c)(3) organization, contributions to which are tax-deductible as permitted by law. Tax ID 58-2492929. 100% of all donations goes to support lupus research programs because the Lupus Research Alliance Board of Directors funds all administrative and fundraising costs. © 2018 Lupus Research Alliance. All rights reserved.

  ---

You may have overpaid

Use your receipts to get money back on your recent purchases